Introduction
Cephalexin is a new cephalosporin antibiotic which, unlike cephaloridine, is well absorbed when given orally (Gower and Dash, 1969) . It has been used in the treatment of urinary tract (Levison et al., 1969) and respiratory infections (Seftel et al., 1969) . Absorption has been claimed to approach 100%, and it has been suggested, therefore, that this antibiotic would have little or no effect on intestinal bacterial flora (Gower and Dash, 1969) . Our own experience does not entirely support these views.
Patients and Methods
Eighteen patients (3 men and 15 women) aged 48 to 81 with urinary tract infection were studied. All organisms were sensitive to cephalexin, a 30-,ug. disc on the primary plate being used. Each patient received cephalexin (Eli Lilly & Co.) 0-5 or 1 g. four times daily for 14 days. Haemoglobin level, haematocrit value, white cell and platelet counts, serum aspartate aminotransferase, alkaline phosphatase, blood urea, and bilirubin were determined before, during, and at the end of treatment. Stool and urine specimens were taken before and during treatment and three days after treatment ended.
During the second week of treatment a 24-hour collection of urine was taken, stored at 4'C. during collection and thereafter at -20'C. At the same time blood samples were taken immediately before and at intervals after the mid-morning dose of cephalexin, which was administered three hours after breakfast and one hour before lunch. Cephalexin levels were measured by a plate assay method, Sarcina lutea (N.C.I.B. 8533) being used as test organism. To avoid observer bias specimens were identified only by a code number.
Results
The serum cephalexin levels in six patients during the three hours after the mid-morning dose are given in Fig. 1 A, and serum cephalexin levels at one hour (18 patients) and four hours (15 patients) after administration in Fig. 1 Of the seven patients acquiring pseudomonas four who were being fed from the hospital diet kitchen acquired the same strain (serotype 6, phage type (119x)), which was known to be present in the diet kitchen at this time. One patient not only showed gut colonization with this strain but subsequently developed a urinary superinfection with it. The change in haemoglobin level during cephalexin treatment was -0.3 ± 0-5 g./100 ml. (mean ± S.E., 12 patients). No change was found in the other laboratory tests.
Discussion
Urinary recovery of cephalexin ranged from 29 to 89% of the daily ingested dose, which is significantly less than that found in healthy volunteers by other workers (Kind et al., 1968; Gower and Dash, 1969) . Peak blood levels occurred at half-hour to two hours (Fig. 1 A) , and the variable rate of absorption is illustrated by the variation in the one-hour blood levels (Fig. 1 B) .
Gower and Dash (1969) suggested that, because of almost complete absorption of cephalexin from the gastrointestinal tract, alteration of bowel flora would be minimal. A significant number of our patients, however, acquired either pseudomonas or proteus in their stools (Table II) , which confirms the view (Shooter et al., 1966 ) that antibiotic therapy may be associated with increased faecal carriage of Ps. aeruginosa.
Our results indicate that ingested organisms may replace or displace organisms in the lower gastrointestinal tract. Hotzel and Barnes (1966) suggested that large-bowel flora is determined in the upper alimentary tract, and that this process is influenced by antibiotic therapy. It has been found that large oral doses of pseudomonas are necessary (101-105 organisms) before it can be detected in the faeces but that colonization is aided by ampicillin (Buck and Cooke, 1969) . Cephalexin may have a similar and more pronounced effect than ampicillin. This would explain the higher carriage rate of pseudomonas in cephalexin-treated patients compared with those not on antibiotic treatment.
Previous reports suggest that patients may become colonized with Ps. aeruginosa ingested in food (Shooter et al., 1969) and that the patient's own gastrointestinal tract may be a source of infection with this organism (Shooter et al., 1966 (Shooter et al., , 1969 . We found that four patients became colonized with the same ingested strain (serotype 6, phage type (119x)) and that one patient subsequently developed a urinary infection with this strain. This confirms that food may be a source of infection in hospital. It must be stressed, however, that this may apply only to the present population, who were known to be ingesting repeated doses of pseudomonas. Individuals living at home are probably not exposed to colonization by pseudomonas to the same extent (Buck and Cooke, 1969) . Acquisition of proteus may have the same basis.
Cephalexin eliminated the infecting organism in 75% of this small series of patients, and the high urinary concentrations obtained (920-4,700 ,ug./ml.) make this an efficient urinary antiseptic. The peak blood levels may also produce a systemic effect.
The pronounced fall in haemoglobin levels found by Meyers et al. (1969) has not been confirmed. 
INTRODUCTION
The treatment of iron-deficiency anaemia with total dose infusion of iron dextran (Imferon) An investigation of response to iron dextran therapy by total dose infusion was planned. All women with (1) pregnancies of less than 36 weeks having haemoglobin levels of 50% or less, and (2) those with pregnancies estimated to be 36 weeks or more with haemoglobin levels of 60% or less were admitted to hospital for investigation and treatment.
Total dose infusion of iron dextran was given to 1,000 patients, 928 pregnant and 72 in the puerperium. They were divided into four equal groups (A, B, C, and D) for the comparison of reaction to total dose infusion. The treatment given in each group is shown in Table I .
The estimated dose of iron dextran was calculated from the manufacturer's suggested formula: milligrams of elemental iron required=0.66 WD, where W=body weight in kilograms and D= % haemoglobin deficit. The infusion was started at
